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Abstract
Background: Patients with atopic dermatitis (AD) can develop autoantibodies against intracellular proteins. AD
patients often suffer from herpes viruses (HV) infection which complicates the inflammatory process in the skin. The
aim of the study was to reveal IgE and IgG antibodies (abs) specific to some skin antigens and to compare their
levels with the severity of AD with HV infection in children.
Methods: IgE and IgG abs specific to tissue antigens, total IgE, IgE-abs to environmental common allergens as well
as IgG abs specific to HV were detected in serum samples by ELISA in 157 AD children.
Results: IgE and IgG antibody production to keratin and elastin was observed in children with AD and elevated
proportionally to the severity of AD. IgG – abs to herpes simplex virus was increased in children and associated
with the severity of clinical course of AD.
Conclusion: Our data shown that clinical course of severe AD is accompanied with autoimmune response to
epidermal antigens (keratin and elastin). Elevated levels of the autoantibodies, especially against the background of
HV infection may be useful serological parameter for monitoring of the disease activity.
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Introduction
Atopic dermatitis (AD) is a chronic pruritic inflamma-
tory skin disease that commonly presents during early
infancy and childhood but can persist or start in adults.
AD is a difficult multiple-factor genetical disease, deter-
mined by increased levels of total IgE and specific IgE
antibodies (abs) to environmental allergens that are im-
portant triggers for this disease [1]. At the same time the
autoimmunity to self-related skin tissue antigens has
been showed in AD patients [2].
During the past decades several IgE- and IgG-binding
autoantigens have been characterized using biochemical and
molecular biological methods. IgE-binding autoantigens
have been listed in the WHO nomenclature as ara Hom S1-
S5 (atopy related antigens Homo sapiens) [3-5]. These
autoantigens can activate Type I hypersensitivity reactions
(atopy) [6]. IgG-abs to cutaneous tissue antigens (CTA) were
also be detected in AD patients [7]. For example, IgG-abs
can bind the protein p80 coilin which takes part in RNA
processing and transmission of the signal into the cell nu-
cleus [8]. In the skin lens epithelium-derived growth factor
(LEDGF/DFS70).
is transported from the nucleus to the cytoplasm of
keratinocytes and is accumulated in the keratohyalin
granules as the keratinocytes differentiate. DFS70 is the
same protein as p75 [9]. Besides, IgE-abs specific to
LEDGF/p75 were also detected in AD patients [10].
Although, most autoantigens are intracellular components
the damaged tissue in the skin of AD patients might induce
the release of autoantigens which then become available to
IgE- and probably to IgG antibodies which can aggravate a
clinical course of the disease [2]. Patients with AD have a
unique predisposition to colonization of the skin by micro-
bial organisms, including herpes viruses (HV) which compli-
cate the course of the inflammatory process in the skin [11]* Correspondence: samoilikov@mail.ru1Mechnikov Research Institute of Vaccines and Sera, Maliy Kazenniy Pereulok
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and in addition, have cross-reactivity with cutaneous anti-
gens [12].
The purpose of the present study was to reveal IgE-
and IgG-abs specific to some skin antigens and to com-
pare their levels with the severity of AD with herpes
virus infection in children.
Methods
Serum samples from 157 AD patients with the age ran-
ging from 1 to 17 years (88 boys and 69 girls) were
tested by ELISA. The AD diagnosis was confirmed using
criteria offered by Hanifin and Rajka [13]. All AD pa-
tients were divided into two age groups: 103 children of
preschool age (from 1 to 6 years, 56 boys and 47 girls)
and 54 children of school age (from 7 to 17 years, 32
boys and 22 girls). Based on the severity of the disease
patients were grouped as follows: 39 children with mild
AD, 55 – moderate AD and 63 – severe AD. Children
with mild or moderate AD received treatment in out-
patient department, while children with severe AD were
treated in the hospital. The severity of AD patients was
assessed using the criteria of SCORAD [14]. For control
purposes, sera from 29 non-atopic healthy children
(from 1 to 17 years, 16 boys and 13 girls) were included.
The study has been approved by the Institutional Ethics
Committee of Mechnikov Research Institute of Vaccines
and Sera (Moscow, Russia) and was performed in ac-
cordance with the Helsinki Declaration of 1975.
Serum IgE- and IgG-abs to tissue antigens were deter-
mined by ELISA. ELISA plates (Costar, USA) were
coated with 100 μl/well of the tissue antigens in concentra-
tion 5 μg/ml dissolved in 0.1 M carbonate buffer (pH 9.6)
and incubated overnight at 4°C. The plates were washed 2
times with washing buffer (PBS, 0.05% Tween 20) and in-
cubated with 1% bovine serum albumin for 2 h at room
temperature (blocking solution). 100 μl/well of patient’s
sera diluted in PBS, 0.05% Tween 20 (1:4 for IgE detection;
1:100 for IgG detection) were added and incubated
for 1 hour at 37°C. Then the plates were washed 3
times with washing buffer followed by adding 100 μl/well
of HRP-conjugated anti-human IgE and IgG detection
mouse monoclonal antibodies (Polignost, Russia) diluted
1:1000 for 1 hour at 37°C. Plates were washed 5 times with
washing buffer and 100 μl/well of tetramethylbenzidine
(Sigma, USA) were added for 20 min at 37°C to develop
color reaction which was stopped by the addition of
100 μl/well of 50% H2SO4. Extinctions (optical densities,
450 nm) were determined with an ELISA reader (Stat Fax -
2100, USA). Optical densities were converted into ME/ml
for IgE-abs and into μg/ml for IgG-abs levels, using stand-
ard reference reagents (Dr. Fooke, Germany). All determi-
nations were carried out in duplicates. The following CTA:
keratin, type III and VI collagen, elastin, myosin (Sigma,
USA) were used for ELISA (Table 1).
The levels of total IgE and specific IgE-abs to environmen-
tal common allergens were detected using ImmunoCAP
100W (Phadia, Sweden). Total IgE in kU/l and specific IgE -
abs in kUA/l were converted into classes according to the
manufacturer’s recommendations: 0 class - less than 0.35
kUA/l; 1 class – from 0.35 to 0.7 kUA/l; 2 class – from 0.7
to 3.5 kUA/l; 3 class – from 3.5 to 17.5 kUA/l; 4 class –
from 17.5 to 50 kUA/l; 5 class – from 50 to 100 kUA/l and
6 class – more than 100 kUA/l).
The levels of IgG-abs to herpes simplex virus (HSV),
cytomegalovirus (CMV) and Epstein-Barr virus (EBV)
were determined using ELISA kits (VECTOR-BEST,
Russia), that included mixed HSV1 and HSV2 antigens,
recombinant CMV antigen and EBNA-1 p72. The levels
of IgG-abs to HSV and EBV were expressed in the units
of optical density while abs to CMV in PE/ml (Paul
Ehrlich Institute units) in accordance with the manufac-
turer’s manual.
Serum samples were obtained from each subject (AD
patients and healthy controls) by venipuncture. The
blood samples were left to clot for up to 60 minutes at
room temperature (22°C) and then centrifuged at 3000
rpm for 10 minutes. Sera were stored until use at −20°C.
The distributions of the received data were not normal
(in accordance with the Kolmogorov-Smirnov test). For
descriptive statistics all data were expressed as median
(Me) and quartile range (QR). A nonparametric Mann–
Whitney U-test was used to compare the levels of total
IgE, IgG-abs to herpes viruses, IgE- and IgG-abs to CTA
in healthy children and AD patients, as well as between
AD patient groups. The correlation between the levels of
total IgE and specific IgE-, IgG-abs to tissue proteins
was assessed using the Spearman index of co-graduation.
All statistical analysis was performed using Microsoft Excel
program and StatSoft Statistica 6 for Windows.
Results
For a serological characterization of the AD disease activity
(manifestation of atopy) we determined the levels of IgE-
abs specific to food, domestic and opportunistic bacterial
allergens and total IgE in serum samples of each subject
(AD patients and healthy control). It was shown that food
allergens were more etiologically significant in children of
pre-school age, while inhalant allergens – in children of
Table 1 Skin distribution of tissue antigens, that were
used in the present study
Antigens Distribution
Keratin Keratin filaments are abundant in keratinocytes
in the cornified layer of the epidermis
Type III and VI collagen Intercellular substance of dermis
Elastin Connective tissue of skin
Myosin Smooth muscle cells of dermis
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school age. For example, 9 children of pre-school age with
mild AD demonstrated IgE-abs specific to milk (39%,
1 class), and 6 children of school age – IgE-abs specific to
D. pteronyssinus and D. farinae (37%, 1 class). 17 children
of pre-school age with moderate AD also shown IgE-abs
specific to milk (41%, 1–3 classes), and 7 children of school
age – IgE-abs specific to animal epidermal allergenss (50%,
1–3 classes). Children with severe AD of pre-school and
school age shown high levels of IgE-abs specific to milk,
egg and house dust mite allergens (1–6 classes).













IgE-abs МЕ/ml IgG-abs μg/ml IgE-abs МЕ/ml IgG-abs μg/ml IgE-abs IgG-abs
Mild 23 26.5 (68) Keratin 1.48 255 1.4 (5.6)* 149.2 (128)* 30.4* 21.7*
Collagen VI 1.4 73 1.4 (0.6) 67.3 (111) 34.8 43.5
Elastin 1.4 48 1.4 (1.0)* 25 (16.3) 34.8* 21.7
Collagen III 1.4 147 1.4 (−) 62.8 (41.9) 21.7 8.7
Myosin 3.1 154 2.06 (2.4) 53.7 (76.8) 34.8 8.7
Moderate 41 107 (275) Keratin 1.48 255 1.67 (7.8) 260.8 (97.4) 60.0 56.1
Collagen VI 1.4 73 1.4 (1.2) 64.8 (56.5) 48.8 41.5
Elastin 1.4 48 1.78 (2.5) 25 (27.1) 53.7 26.8
Collagen III 1.4 147 1.4 (3.17) 73.7 (88.4) 48.8 19.5
Myosin 3.1 154 2.88 (9.0) 83 (162.3) 46.3 26.8
Severe 39 360 (1080) Keratin 1.48 255 2.16 (5.58)* ** 291.5 (496.6)* ** 61.5* 56.4*
Collagen VI 1.4 73 1.4 (−) 27.2 (26.7) 15.4 15.4
Elastin 1.4 48 1.81 (0.49)* ** 25 (16.9) 53.9* 23.1
Collagen III 1.4 147 1.4 (−) 25 (40.3) 12.8 5.1
Myosin 3.1 154 1.4 (−) 40.8 (104.5) 10.3 20.5
* – valid differences in the levels of IgE- and IgG-abs to tissue antigens between mild and severe AD patient groups (p < 0.05).
** – valid increased levels of IgE- and IgG-abs to tissue antigens (p < 0.05).












IgE-abs МЕ/ml IgG-abs μg/ml IgE-abs МЕ/ml IgG-abs μg/ml IgE-abs IgG-abs
Mild 16 19 (36) Keratin 1.48 206 1.7 (4.68)* 209.8 (213.5)* 50* 68.8*
Collagen VI 1.4 49 1.4 (1.2) 82.5 (156.1)** 31.3 62.5
Elastin 1.4 25 1.4 (1.07)* 25 (56.8) 43.8* 31.3
Collagen III 1.4 54 1.4 (0.71) 45.2 (77.5) 31.3 43.8
Myosin 3.1 200 1.87 (9.5) 25 (140.5) 43.8 18.8
Moderate 14 72 (133) Keratin 1.48 206 1.87 (1.5) 281.1 (90.5)** 57.1 71.4
Collagen VI 1.4 49 1.4 (0.05) 59.1 (49.4) 28.6 57.1
Elastin 1.4 25 1.48 (1.0) 38.3 (104.5) 57.1 50
Collagen III 1.4 54 1.4 (−) 50.9 (70.8) 21.4 42.9
Myosin 3.1 200 1.4 (1.92) 136.6 (147) 28.6 21.4
Severe 24 128 (471) Keratin 1.48 206 2.71 (12.29)* ** 296.2 (214.1) * ** 62.5* 75*
Collagen VI 1.4 49 1.4 (−) 25 (18.3) 4.2 29.2
Elastin 1.4 25 2.69 (1.38)* ** 25 (10.7) 58.3* 29.17
Collagen III 1.4 54 1.4 (−) 25 (33.5) 8.3 29.2
Myosin 3.1 200 1.4 (−) 40.29 (60.2) 8.3 16.7
* – valid differences in the levels of IgE- and IgG-abs to tissue antigens between mild and severe AD patient groups (p < 0.05).
** – valid increased levels of IgE- and IgG-abs to tissue antigens (p < 0.05).
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The levels of total IgE in all AD patients groups were
higher than that of healthy subjects of the same age and
were increased in proportion to the severity of AD
within the range from 1 to 5000 kU/l. The maximal level
of total IgE was observed in pre-school age children with
severe AD [Me = 360 kU/l (1080)] (Tables 2 and 3).
Before evaluation of autoimmune reactions to CTA
were detected in the serum samples of healthy subjects.
It was shown that in healthy children the levels of IgE-
abs to CTA were very low and did not differ between
groups of pre-school and school age children. IgE-abs to
CTA were as follows: to keratin - below 1.48 ME/ml; to
collagen III, collagen VI and elastin - below 1.4 ME/ml;
to myosin - below 3.1 ME/ml. The levels of IgG-abs to
these antigens were presented in Tables 2 and 3. We ac-
cepted these data as a cut-off value (a sum of median
levels of these antibodies and quartile range) and all the
values of IgG-abs to CTA in AD patient’s groups that
were above cut-off value were considered as the elevated
autoantibody levels in serum samples.
IgE-abs specific to CTA were detected in the sera of chil-
dren with AD. It was shown that the levels and the fre-
quency of detection of IgE-abs specific to keratin and
elastin were increased in proportion to the severity of AD
(Figures 1 and 2 and Tables 2 and 3). The levels of these
IgE-abs in sera of severe AD patients were significantly
higher (pre-school age children: keratin – 2.16 (5.58) ME/
ml and to elastin – 1.81 (0.49) ME/ml; school age children:
keratin – 2.71 (12.29) ME/ml), elastin – 2.69 (1.38) ME/
ml) in comparison with both mild AD patients (pre-school
age: keratin – 1.4 (5.6) ME/ml, elastin – 1.4 (1.0) ME/ml;
school age: keratin – 1.7 (4.68) ME/ml), elastin – 1.4 (1.07)
ME/ml) and healthy children group (p < 0.05). The levels
of IgE-abs to other CTA were normal or insignificantly in-
creased (p > 0.05). The positive correlation was found be-
tween the levels of total IgE and IgE-abs specific to keratin
in children with severe AD (r = 0.35; p < 0.05).
The levels and the frequency of detection of IgG-abs
to keratin were also being increased in proportion to the
severity of AD (Figure 3 and Tables 2 and 3). In children
with severe AD the levels of these abs were also higher
(preschool age: keratin – 291.5 (496.6) μg/ml; school
age: keratin – 296.2 (214.1) μg/ml), than that of children
with both mild AD (preschool age: keratin – 149.2 (128)
μg/ml; school age: keratin – 209.8 (213.5) μg/ml) and
healthy group (p < 0.05). In addition, we found substan-
tially higher levels of IgG-abs specific to collagen VI in
children of school age with mild AD, specific to keratin
in children of school age with moderate AD and to kera-
tin in children of pre- and school age with severe AD in
compare to healthy children group. There were no sig-
nificant differences in the levels of IgE and IgG autoanti-
bodies between mild and moderate AD patient groups
as well as between moderate and severe AD patient
groups.
IgG-abs specific to CMV and EBV were increased in all
age groups of patients with AD in comparison with cut-
off value (children of preschool age – max CMV Me=
2.43 (5.24) ЕР/ml, max EBV Me =2.59 (0.98); children of
Figure 1 The levels of IgE-abs to keratin and quartile range
against severity of AD. Normal levels of these abs are under 1,48
ME/ml. * – valid differences in the levels of IgE-abs to keratin
between groups. ** – valid increased levels of IgE-abs to keratin.
Figure 2 The levels of IgE-abs to elastin and quartile range
against severity of AD. Normal levels of these abs are under 1,4
ME/ml. * – valid differences in the levels of IgE-abs to elastin
between groups. ** – valid increased levels of IgE-abs to elastin.
Figure 3 The levels of IgG-abs to keratin and quartile range
against severity of AD. * – valid differences in the levels of IgG-abs
to keratin between groups. ** – valid increased levels of IgG-abs
to keratin.
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school age – max CMV Me= 6.07 (6.13) ЕР/ml, max EBV
Me = 2.75 (0.57)). While IgG-abs specific to CMV and
EBV in AD patients of all age groups reflected the dy-
namic of immune response in the population as a whole,
the level and the frequency of detection of HSV-IgG-abs
were increased in children of school age and associated
with severity of clinical course of AD (see Tables 4 and 5).
Discussions
In the present study we have expanded the list of
autoantigens which may play pathogenetic role in the
development of severe AD. At first for serological
characterization of the atopic disease we determined
total IgE and specific IgE in serum samples of AD pa-
tients and healthy persons. Taking into consideration of
a large variety of clinically relevant allergens in the de-
veloping of AD we used a total IgE level as some kinds
of universal sign of disease activity in comparison with
the intensity of autoimmune reactions. It has been
showed, that children with mild or moderate AD had
much lower levels of total IgE compared to severe AD
children [15]. At the same time it is quite understand-
able that total IgE level is not unique characterization of
disease activity. In this connection we decided to explore
the development of autoreactivity, in particular, IgE, and
IgG antibody response to autoantigens in AD patients
with different degrees of disease activity.
In the beginning IgE- and IgG-abs to some endogen-
ous antigens in healthy persons were determined to find
cut-off value. Next, we divided all AD patients into two
age groups (preschool age and school age) because the
levels of IgG-autoantibodies were different in healthy
children of those age groups, whereas the levels of IgE-
antibodies were very low and were not depended on the
age. Establishing the reliable cut-off value gave oppor-
tunity to determine the increased levels IgE- and IgG-
abs to skin antigens in AD patients. We were shown that
AD patients with high levels of IgE- and IgG-reactivity
to keratin and elastin may demonstrate much more se-
vere manifestations of the disease.





Antigens Levels of IgG-abs Frequency of occurrence
of IgG-abs in patients, %Cut-off (in HV-negative people) In children with AD, Me (QR)
Mild 23 HSV 0.223 0.169 (1.28) 34.78
CMV 0.2 0.39* (3.72) 91.3
EBV 0.45 2.19* (1.37) 95.65
Moderate 41 HSV 0.223 0.173 (2.53) 46.34
CMV 0.2 1.2* (5.43) 92.68
EBV 0.45 2.59* (0.98) 92.68
Severe 39 HSV 0.223 0.23 (2.81) 51.28
CMV 0.2 2.43* (5.24) 89.74
EBV 0.45 0.86* (1.87) 92.31
The levels of IgG-abs to HSV and EBV are in units of OD. The levels of IgG-abs to CMV are in ЕР/ml.
* – valid differences in the levels of IgG-abs to herpes viruses between children with AD and HV-negative people (p < 0.05).





Antigens Levels of IgG-abs Frequency of occurrence
of IgG-abs in patients, %Cut-off (in HV-negative people) In children with AD, Me (QR)
Mild 16 HSV 0.223 0.19 (2.68) 43.75
CMV 0.2 6.07* (6.13) 93.75
EBV 0.45 2.75* (0.57) 87.5
Moderate 14 HSV 0.223 0.21 (2.65) 50
CMV 0.2 4.59* (5.67) 92.86
EBV 0.45 2.63* (1.82) 92.86
Severe 24 HSV 0.223 2.93* (3.01) 70.83
CMV 0.2 1.35* (5.48) 91.67
EBV 0.45 2.04* (2.45) 91.67
The levels of IgG-abs to HSV and EBV are in units of OD. The levels of IgG-abs to CMV are in ЕР/ml.
* – valid differences in the levels of IgG-abs to herpes viruses between children with AD and HV-negative people (p < 0.05).
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In addition to that the positive correlation between the
levels of total IgE and IgE-abs specific to keratin was ob-
served in children with severe AD (p < 0.05). In our work
we used mixed type of keratin which consisted of both
intracellular (cytoskeleton of keratinocytes in the epidermis)
and extracellular proteins (stratum corneum of the epider-
mis) and elastin which was an extracellular protein of con-
nective tissue of dermis. These intra- and extracellular
protein components of skin can be liberated at the sites of
tissue damage and became available to IgE- and IgG-abs.
Intracellular IgE-specific autoantigens appear to be released
into circulation and occured as IgE immune complexes,
which might reach the target organs of AD that could lead
to the release of biological mediators through binding to ef-
fector cells (e.g. mast cells, basophiles, eosinophils). IgE-
mediated presentation of autoallergens may also activate
autoreactive T cells to release pro-inflammatory cytokines,
inducing those for mediating of the delayed-type hypersen-
sitivity reactions [2].
On the other hand the development of autoimmune re-
sponses may be linked to cross-reactive antigens. Some en-
vironmental proteins have similar structural homology
with human proteins. IgG-abs to P-62 protein (synthetic
protein similar to one of EBV antigens) can react with hu-
man epidermal keratin, denatured type II collagen and
actin [12]. Moreover, herpes viruses can induce apoptosis
of CD4+CD25+Foxp3 Тreg cells by mean of CD95-L inter-
action with infected dendritic cells [16,17], that might re-
duce the regulatory function of the immune system. In
case of inflammation in the skin it promotes the release of
autoantigens and leads to increase of autoantibodies in AD
patients. Chronic skin inflammation in AD patients may
cause some abnormalities in the activity of lymphocytes
that may promote the development of autoimmune reac-
tions. The autoantibodies to skin tissue antigens might not
directly involved in pathogenesis of AD but may be the
markers of target tissue injury leading to the provocation
of an autoimmune response [18].
Our results show that clinical course of the severe AD is
accompanied by the autoimmune response to epidermal
antigens (keratin and elastin). The detection of the elevated
levels of the autoantibodies, especially against the back-
ground of herpetic virus infection can improve the diag-
nostic criteria of AD severity and allow clinicians to choose
the most safe and effective treatment of AD patients.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
PS: adaptation of the ELISA kits to determine serum IgE- and IgG-abs to tissue
antigens, carrying out of the tissue autoantibody and HV-IgG-abs studies,
participation in the analysis of the data and the preparation of the manuscript.
VG: the idea of this study, the leadership of the work, participation in the analysis
of the data, discussion of the results and the preparation of the manuscript.
SK: carrying out of clinical work, diagnosis, preparation of biomaterial for the
study. All authors read and approved the final manuscript.
Acknowledgement
Parts of this paper were presented at the 2011 World Allergy Congress in
Cancun in December.
Author details
1Mechnikov Research Institute of Vaccines and Sera, Maliy Kazenniy Pereulok
5a, 103064, Moscow, Russia. 2Research Institute of Pediatrics and Pediatric
Surgery, Taldomskaay 2, 125412, Moscow, Russia.
Received: 1 September 2012 Accepted: 24 April 2013
Published: 29 April 2013
References
1. Spergel J: Epidemiology of atopic dermatitis and atopic march in
children. Immunol Allergy Clin North Am 2010, 30(3):269–280.
2. Muro Y: Autoantibodies in atopic dermatitis. J Dermatol Sci 2001,
25:171–178.
3. Valenta R, Natter S, Seiberler S, et al: Molecular characterization of an
autoallergen, Hom s 1, identified by serum IgE from atopic dermatitis
patients. J Invest Dermatol 1998, 111(6):1178–1183.
4. Valenta R, Maurer D, Steiner R, et al: Immunoglobulin E response to
human proteins in atopic patients. J Invest Dermatol 1996, 107(2):203–207.
5. Mossabeb R, Seiberler S, Mittermann I, et al: Characterization of a novel
isoform of alpha-nascent polypeptide-associated complex as IgE-defined
autoantigen. J Invest Dermatol 2002, 119(4):820–829.
6. Natter S, Seiberler S, Hufnagl P, et al: Isolation of cDNA clones coding for
IgE autoantigens with serum IgE from atopic dermatitis patients. J FASEB
1998, 12:1559–1569.
7. Seiberler S, Natter S, Hufnagl P, et al: Characterization of IgE-reactive
autoantigens in atopic dermatitis. 2. A pilot study on IgE versus IgG
subclass response and seasonal variation of IgE autoreactivity. Int Arch
Allergy Immunol 1999, 120(2):117–125.
8. Goto N, Sugiura K, Ogawa Y, et al: Anti-p80 coilin autoantibodies react
with a conserved epitope and are associated with anti-DFS70/LEDGF
autoantibodies. J Autoimmun 2006, 26(1):42–51.
9. Sugiura K, Muro Y, Nishizawa Y, et al: LEDGF/DFS70, a major autoantigen
of atopic dermatitis, is a component of keratohyalin granules. J Invest
Dermatol 2007, 127(1):75–80.
10. Watanabe K, Muro Y, Sugiura K, Tomita Y: IgE and IgG(4) autoantibodies
against DFS70/LEDGF in atopic dermatitis. Autoimmunity 2011,
44(6):511–519.
11. Boguniewicz M, Leung DY: Atopic dermatitis: a disease of altered skin
barrier and immune dysregulation. Immunol Rev 2011, 242(1):233–246.
12. Baboonian C, Venables PJ, Williams DG, et al: Cross reaction of antibodies
to a glycine/alanine repeat sequence of Epstein-Barr virus nuclear
antigen-1 with collagen, cytokeratin, and actin. Ann Rheum Dis 1991,
50(11):772–775.
13. Hanifin JM, Rajka G: Diagnostic features of atopic dermatitis. Acta Derm
Venerol Suppl (Stockh) 1980, 92:44–47.
14. Dermatology (Basel)Severity scoring of atopic dermatitis: the SCORAD
index. Consensus Report of the European Task Force on Atopic
Dermatitis. 1993, 186(1):23–31.
15. Cork MJ, Robinson DA, Vasilopoulos Y, et al: New prescriptive on
epidermal barrier dysfunction in AD; Gene environmental interaction.
J Allergy Clin Immunol 2006, 118:3–21.
16. Fritzsching B, Oberle N, Eberhardt N, et al: In contrast to effector T cells,
CD4+CD25+Foxp3+ regulatory T cells are highly susceptible to CD95
ligand- but not to TCR-mediated cell death. J Immunol 2005, 175(1):32–36.
17. Raftery MJ, Schwab M, Eibert SM, et al: Targeting the function of mature
dendritic cells by human cytomegalovirus: a multilayered viral defense
strategy. Immunity 2001, 15(6):997–1009.
18. Tan EM: Autoantibodies as diagnostic markers and reporters on the
nature of immunogenic autoantigens. Immunologist 1999, 7:85–92.
doi:10.1186/1939-4551-6-8
Cite this article as: Samoylikov et al.: Association between autoimmune
reactions and severity of atopic dermatitis in children
with herpes virus infection. World Allergy Organization Journal 2013 6:8.
Samoylikov et al. World Allergy Organization Journal 2013, 6:8 Page 6 of 6
http://new.waojournal.org/content/6/1/8
